These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10103200)

  • 1. Pharmacokinetics of beta-L-2',3'-dideoxy-5-fluorocytidine in rhesus monkeys.
    Martin LT; Cretton-Scott E; Schinazi RF; Zhou XJ; McClure HM; Mathe C; Gosselin G; Imbach JL; Sommadossi JP
    Antimicrob Agents Chemother; 1999 Apr; 43(4):920-4. PubMed ID: 10103200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of the antiviral agent beta-D-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine in rhesus monkeys.
    Ma L; Hurwitz SJ; Shi J; Mcatee JJ; Liotta DC; McClure HM; Schinazi RF
    Antimicrob Agents Chemother; 1999 Feb; 43(2):381-4. PubMed ID: 9925539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of 2',3'-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV).
    Lin TS; Luo MZ; Liu MC; Pai SB; Dutschman GE; Cheng YC
    J Med Chem; 1994 Mar; 37(6):798-803. PubMed ID: 8145230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral activity of 2',3'-dideoxy-beta-L-5-fluorocytidine (beta-L-FddC) and 2',3'-dideoxy-beta-L-cytidine (beta-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro.
    Lin TS; Luo MZ; Liu MC; Pai SB; Dutschman GE; Cheng YC
    Biochem Pharmacol; 1994 Jan; 47(2):171-4. PubMed ID: 8304960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of the antiviral agent beta-L-3'-fluoro-2',3'-didehydro-2',3'-dideoxycytidine in rhesus monkeys.
    Asif G; Hurwitz SJ; Gumina G; Chu CK; McClure HM; Schinazi RF
    Antimicrob Agents Chemother; 2005 Feb; 49(2):560-4. PubMed ID: 15673733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, oral bioavailability, and metabolism in mice and cynomolgus monkeys of (2'R,5'S-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, an agent active against human immunodeficiency virus and human hepatitis B virus.
    Frick LW; Lambe CU; St John L; Taylor LC; Nelson DJ
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2722-9. PubMed ID: 7695253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and metabolism of 3'-azido-2',3'-dideoxy-5-methylcytidine in rhesus monkeys.
    Boudinot FD; Schinazi RF; Doshi KJ; McClure HM; Chu CK
    Drug Metab Dispos; 1993; 21(5):855-60. PubMed ID: 7902248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and metabolism of racemic 2',3'-dideoxy-5-fluoro-3'-thiacytidine in rhesus monkeys.
    Schinazi RF; Boudinot FD; Ibrahim SS; Manning C; McClure HM; Liotta DC
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2432-8. PubMed ID: 1336946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of stereoisomerism on the cellular pharmacology of beta-enantiomers of cytidine analogs in Hep-G2 cells.
    Martin LT; Faraj A; Schinazi RF; Gosselin G; Mathe C; Imbach JL; Sommadossi JP
    Biochem Pharmacol; 1997 Jan; 53(1):75-87. PubMed ID: 8960066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of saquinavir, zidovudine, and zalcitabine in combination therapy.
    Vanhove GF; Kastrissios H; Gries JM; Verotta D; Park K; Collier AC; Squires K; Sheiner LB; Blaschke TF
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2428-32. PubMed ID: 9371345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virus.
    Frick LW; St John L; Taylor LC; Painter GR; Furman PA; Liotta DC; Furfine ES; Nelson DJ
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2285-92. PubMed ID: 8285607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of lamivudine and BCH-189 in plasma and cerebrospinal fluid of nonhuman primates.
    Blaney SM; Daniel MJ; Harker AJ; Godwin K; Balis FM
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2779-82. PubMed ID: 8593019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetics of Racivir, (+/-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine in rats, rabbits, dogs, monkeys and HIV-infected humans.
    Hurwitz SJ; Otto MJ; Schinazi RF
    Antivir Chem Chemother; 2005; 16(2):117-27. PubMed ID: 15889534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of 2',3'-dideoxy-5-fluoro-3'-thiacytidine in rats.
    Abobo CV; Ni L; Schinazi RF; Liotta DC; Boudinot FD
    J Pharm Sci; 1994 Jan; 83(1):96-9. PubMed ID: 8138919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human immunodeficiency virus type 1 reverse transcriptase by the 5'-triphosphate beta enantiomers of cytidine analogs.
    Faraj A; Agrofoglio LA; Wakefield JK; McPherson S; Morrow CD; Gosselin G; Mathe C; Imbach JL; Schinazi RF; Sommadossi JP
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2300-5. PubMed ID: 7530932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zalcitabine population pharmacokinetics: application of radioimmunoassay.
    Adams JM; Shelton MJ; Hewitt RG; DeRemer M; DiFrancesco R; Grasela TH; Morse GD
    Antimicrob Agents Chemother; 1998 Feb; 42(2):409-13. PubMed ID: 9527795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of (-)-beta-D-dioxolane guanine and prodrug (-)-beta-D-2,6-diaminopurine dioxolane in rats and monkeys.
    Chen H; Schinazi RF; Rajagopalan P; Gao Z; Chu CK; McClure HM; Boudinot FD
    AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1625-30. PubMed ID: 10606085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral activity and pharmacokinetics of 1-(2,3-dideoxy-2-fluoro-beta-L-glyceropent-2-enofuranosyl)cytosine.
    Chen H; Pai SB; Hurwitz SJ; Chu CK; Glazkova Y; McClure HM; Feitelson M; Schinazi RF
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1922-8. PubMed ID: 12760868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-human immunodeficiency virus activities of the beta-L enantiomer of 2',3'-dideoxycytidine and its 5-fluoro derivative in vitro.
    Gosselin G; Schinazi RF; Sommadossi JP; Mathé C; Bergogne MC; Aubertin AM; Kirn A; Imbach JL
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1292-7. PubMed ID: 8092827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.